iOrganBio

Make the right cells, consistently, at scale. iOrganBio is transforming human cell production with CellForge, an intelligent, automated manufacturing platform that monitors digitized cell states and uses AI to steer differentiation toward true in vivo targets. The result is reproducible, high-quality cells and organoids for in vitro disease modeling, preclinical studies, and cell therapy manufacturing.

What we offer
• CellForge Platform: Automated cell manufacturing that tracks semi-continuous scRNAseq signals and applies AI control to keep cultures on target.
• CellForge Discovery: High-throughput, automated culture system for building and validating new or improved differentiation protocols.
• CellForge Manufacturing: Reliable production of cell products with deep transcriptomics for culture monitoring and maintenance.

Recent milestone
iOrganBio closed a 2 million dollar pre-seed round led by First Star Ventures, with participation from IndieBio, Cape Fear BioCapital, 2ndF, Terasaki Institute, and Alix Ventures. Funding will accelerate CellForge development and the drive toward bioequivalent cells produced reproducibly and at scale.